All News

Urovant Sciences Enters into Flexible Agreement for up to $100 Million Debt Financing with Hercules Capital

Ref: Business Wire

Tags: Press Release Urovant Sciences Corporate Affairs

Intellipharmaceutics Announces Fiscal Year 2018 Results

Ref: Accesswire

Tags: Press Release Intellipharmaceutics Corporate Affairs

Bristol-Myers Squibb Announces Filing of Definitive Proxy Statement in Connection with Proposed Merger with Celgene

Ref: Business Wire

Tags: Press Release BMS Celgene Corporate Affairs Mergers & Acquisitions

Study links Celebrex, heart valve calcification after earlier research declared drug safe

Ref: Vanderbilt University

Tags: Press Release Valvular Heart Disease Arthritis Clinical Research (R&D)Celebrex ibuprofen naproxen

ICER to Publish Upcoming Assessment on Additive Cardiovascular Disease Therapies

Ref: ICER

Tags: Press Release Amarin J&J ICER Marketing & Sales Vascepa Xarelto

Sinovac Determines Trigger Event Occurred Under Rights Agreement

Ref: Business Wire

Tags: Press Release Sinovac Corporate Affairs Mergers & Acquisitions

US Senators launch bipartisan investigation into rising insulin prices

Ref: CNBC

Tags: NewsPoints Lilly Novo Nordisk Sanofi Diabetes Marketing & Sales

FDA updates prescribing information for Chantix (varenicline) with data underscoring it’s not effective in children 16 and younger

Ref: FDA

Tags: Press Release Addictions FDA Regulatory Affairs Marketing & Sales Chantix

Nasdaq Halts Sinovac Biotech Ltd.

Ref: GlobeNewswire

Tags: Press Release Sinovac Corporate Affairs

Abivax to Present Latest Clinical and Mechanism of Action Data on its Lead Compound ABX464 at Two Upcoming Conferences

Ref: Business Wire

Tags: Press Release ABIVAX IBD AIDS and HIV Clinical Research (R&D) Medical Affairs ABX464